Kunio Suzuki

Director/Board Member at Banyu Pharmaceutical Co. Ltd.

Health Technology

Consumer Services

Profile

Kunio Suzuki is currently a Director at Banyu Pharmaceutical Co. Ltd.
and a Member-Supervisory Board at REGiMMUNE Corp.
He obtained his undergraduate and graduate degrees from Nagoya University and his doctorate from the University of Shizuoka.

Kunio Suzuki active positions

Companies	Position	Start
Banyu Pharmaceutical Co. Ltd. Banyu Pharmaceutical Co. Ltd. Pharmaceuticals: MajorHealth Technology Banyu Pharmaceutical Co. Ltd. produces and distributes pharmaceutical products. It researches, develops, manufactures, sells, and imports and exports ethical drugs in Japan. Banyu Pharmaceutical was founded in 1915 and is headquartered in Tokyo, Japan.	Director/Board Member	2009-07-14
REGiMMUNE Corp. REGiMMUNE Corp. Pharmaceuticals: MajorHealth Technology REGiMMUNE Corp. develops solutions for treating immune disorders. Its focus is on the discovery, development, and commercialization of immune regulatory therapeutics to treat life-threatening and debilitating conditions, including allergies, autoimmune diseases and transplantation. The firm's platform technology, reVax, induces immune tolerance in an antigen-specific manner through pharmacological induction of regulatory T (Treg) cells. It also develops products for preventing inhibitor formation in enzyme replacement therapies (ERT) and for celiac disease with undisclosed partners. The company was founded by Yasuyuki Ishii on March 3, 2006 and is headquartered in Tokyo, Japan.	Director/Board Member	-

All active positions of Kunio Suzuki

Training of Kunio Suzuki

Nagoya University	Graduate Degree
University of Shizuoka	Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Kunio Suzuki's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	2
Banyu Pharmaceutical Co. Ltd. Banyu Pharmaceutical Co. Ltd. Pharmaceuticals: MajorHealth Technology Banyu Pharmaceutical Co. Ltd. produces and distributes pharmaceutical products. It researches, develops, manufactures, sells, and imports and exports ethical drugs in Japan. Banyu Pharmaceutical was founded in 1915 and is headquartered in Tokyo, Japan.	Health Technology
REGiMMUNE Corp. REGiMMUNE Corp. Pharmaceuticals: MajorHealth Technology REGiMMUNE Corp. develops solutions for treating immune disorders. Its focus is on the discovery, development, and commercialization of immune regulatory therapeutics to treat life-threatening and debilitating conditions, including allergies, autoimmune diseases and transplantation. The firm's platform technology, reVax, induces immune tolerance in an antigen-specific manner through pharmacological induction of regulatory T (Treg) cells. It also develops products for preventing inhibitor formation in enzyme replacement therapies (ERT) and for celiac disease with undisclosed partners. The company was founded by Yasuyuki Ishii on March 3, 2006 and is headquartered in Tokyo, Japan.	Health Technology